Cargando…
Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer
PURPOSE: The clinical utility of plasma methylated septin 9 (mSEPT9) DNA in screening and recurrence monitoring for colorectal cancer (CRC) is highly promising. The present study was performed to determine the diagnostic value of mSEPT9 in CRC detection and recurrence monitoring in Chinese patients....
Autores principales: | Lu, Pingxia, Zhu, Xianjin, Song, Yanfang, Luo, Yue, Lin, Junsheng, Zhang, Junrong, Cao, Yingping, Huang, Zhengyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271001/ https://www.ncbi.nlm.nih.gov/pubmed/35818587 http://dx.doi.org/10.1155/2022/7087885 |
Ejemplares similares
-
Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis
por: Huang, Zhengyuan, et al.
Publicado: (2022) -
Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer
por: Zhu, Xianjin, et al.
Publicado: (2018) -
Clinical Usefulness and Prognostic Value of Red Cell Distribution Width in Colorectal Cancer
por: Song, Yanfang, et al.
Publicado: (2018) -
Methylated Septin9 (mSEPT9): A Promising Blood-Based Biomarker for the Detection and Screening of Early-Onset Colorectal Cancer
por: Loomans-Kropp, Holli A., et al.
Publicado: (2022) -
Diagnostic Value of Methylated Septin9 for Colorectal Cancer Detection
por: Xie, Li, et al.
Publicado: (2018)